Three children with congenital toxoplasmosis: Early report from a Swedish prospective screening study

Acta Paediatrica, International Journal of Paediatrics

Volumn 88, Issue 6, 1999, Pages 667-670

  Malm, G ^a   Tear Fahnehjelm K ^a   Wiklund, S ^b   Engman, M L ^a   Ivarsson, S A ^b   Petersson, K ^a   Evengard B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Congenital toxoplasmosis; Guthrie cards; Screening study

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCEPHALUS; INCIDENCE; MALE; MICROPHTHALMIA; NEWBORN; PRENATAL SCREENING; PRIORITY JOURNAL; SWEDEN;

ANTI-BACTERIAL AGENTS; ANTIBODIES, PROTOZOAN; CEREBROSPINAL FLUID SHUNTS; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; HUMANS; HYDROCEPHALUS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SPIRAMYCIN; SWEDEN; TIME FACTORS; TOXOPLASMOSIS, CONGENITAL;

EID: 2442721422     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259950169369     Document Type: Article

References (15)

1. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and the newborn infant. 4th ed. Philadelphia, PA: Saunders, 1995: 140-267
2. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20 year follow-up of congenital toxoplasmosis. Lancet 1986; i: 254-53
3. Wilson CB, Remington JS, Stagnio S, Reynoldas DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980; 66: 767-74
4. Hohlfeld P, Dafos F, Thulliéz P, Aufrant C, Couvreur J, MacAleese J, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989; 115: 765-9
5. Daffos F, Forestier F, Capella-Pavlovsky M, Thullierz P, Aufrant C, Valenti D, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271-5
6. Guerina NG, Hsu H-W, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858-63
7. Roizen N, Swisher CN, Stein MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95: 11-20
8. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994: 18-72
9. Forsgren M, Gille E, Ljungström I, Nokes DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979 and 1987. Lancet 1991; 337: 1413-4
10. Desmonts G, Naot Y, Remmington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired toxoplasma infections. J Clin Microbiol 1981; 14: 486-91
11. Bessieres MH, Roque C, Berrebi A, Barre V, Cazaux M, Seguels JP. IgA response during acquired and congenital toxoplasmosis. J Clin Pathol 1992; 45: 605-8
12. Lappalainen M, Koskiniemi M, Hiilesma V, Ammala P, Teramo K, Koskela P, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995; 14: 354-61
13. Petersen E. Laboratory of Parasitology, WHO/FAO International Centre for Research and Reference on Toxoplasmosis, Statens Seruminstitut, 2100 Copenhagen, Denmark
14. Patel DV, Holfels EM, Vogel NP, Boyer KM, Mets MB, Swisher CN, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996; 199: 433-40
15. Virkola K, Lappalainen M, Valanne L, Koskiniemi M. Radiological signs in newborns exposed to primary Toxoplasma infection in utero. Pediatr Radiol 1997; 27: 133-8